Cytek BioSciences Inc(NASDAQ:CTKB) 
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue, net: | ||||||||||||||||||||
product | 28,779,000 | 46,594,000 | 38,114,000 | 31,415,000 | 28,110,000 | 45,021,000 | 39,544,000 | 34,576,000 | 34,122,000 | 46,652,000 | 38,441,000 | 40,452,000 | 31,172,000 | 43,637,000 | 36,389,000 | 37,093,000 | 31,481,000 | 35,952,000 | 32,191,000 | 28,676,000 |
service | 15,356,000 | 15,547,000 | 14,179,000 | 14,187,000 | 13,347,000 | 12,455,000 | 11,956,000 | 12,041,000 | 10,738,000 | 11,581,000 | 9,559,000 | 9,241,000 | 5,916,000 | 4,699,000 | 4,088,000 | 3,066,000 | 3,583,000 | 2,942,000 | 2,185,000 | 1,732,000 |
total revenue | 44,135,000 | 62,141,000 | 52,293,000 | 45,602,000 | 41,457,000 | 57,476,000 | 51,500,000 | 46,617,000 | 44,860,000 | 58,233,000 | 48,000,000 | 49,693,000 | 37,088,000 | 48,336,000 | 40,477,000 | 40,159,000 | 35,064,000 | 38,894,000 | 34,376,000 | 30,408,000 |
yoy | 6.46% | 8.12% | 1.54% | -2.18% | -7.59% | -1.30% | 7.29% | -6.19% | 20.96% | 20.48% | 18.59% | 23.74% | 5.77% | 24.28% | 17.75% | 32.07% | ||||
qoq | -28.98% | 18.83% | 14.67% | 10.00% | -27.87% | 11.60% | 10.47% | 3.92% | -22.96% | 21.32% | -3.41% | 33.99% | -23.27% | 19.42% | 0.79% | 14.53% | -9.85% | 13.14% | 13.05% | |
cost of sales: | ||||||||||||||||||||
total cost of sales | 22,881,000 | 29,256,000 | 24,742,000 | 21,735,000 | 21,300,000 | 23,824,000 | 22,495,000 | 21,181,000 | 21,847,000 | 25,185,000 | 20,822,000 | 21,531,000 | 16,050,000 | 18,962,000 | 13,615,000 | 15,598,000 | 14,887,000 | 15,258,000 | 13,099,000 | 10,663,000 |
gross profit | 21,254,000 | 32,885,000 | 27,551,000 | 23,867,000 | 20,157,000 | 33,652,000 | 29,005,000 | 25,436,000 | 23,013,000 | 33,048,000 | 27,178,000 | 28,162,000 | 21,038,000 | 29,374,000 | 26,862,000 | 24,561,000 | 20,177,000 | 23,636,000 | 21,277,000 | 19,745,000 |
yoy | 5.44% | -2.28% | -5.01% | -6.17% | -12.41% | 1.83% | 6.72% | -9.68% | 9.39% | 12.51% | 1.18% | 14.66% | 4.27% | 24.28% | 26.25% | 24.39% | ||||
qoq | -35.37% | 19.36% | 15.44% | 18.41% | -40.10% | 16.02% | 14.03% | 10.53% | -30.36% | 21.60% | -3.49% | 33.86% | -28.38% | 9.35% | 9.37% | 21.73% | -14.63% | 11.09% | 7.76% | |
gross margin % | 48.16% | 52.92% | 52.69% | 52.34% | 48.62% | 58.55% | 56.32% | 54.56% | 51.30% | 56.75% | 56.62% | 56.67% | 56.72% | 60.77% | 66.36% | 61.16% | 57.54% | 60.77% | 61.89% | 64.93% |
operating expenses: | ||||||||||||||||||||
research and development | 9,604,000 | 8,962,000 | 8,956,000 | 8,826,000 | 9,725,000 | 9,723,000 | 9,882,000 | 10,001,000 | 9,796,000 | 10,869,000 | 11,171,000 | 12,136,000 | 9,974,000 | 9,747,000 | 8,650,000 | 8,436,000 | 8,025,000 | 7,076,000 | 6,078,000 | 6,194,000 |
sales and marketing | 11,646,000 | 13,131,000 | 11,666,000 | 12,134,000 | 12,509,000 | 11,874,000 | 12,429,000 | 12,268,000 | 12,543,000 | 11,561,000 | 12,076,000 | 14,367,000 | 11,145,000 | 9,029,000 | 8,810,000 | 8,431,000 | 6,960,000 | 8,304,000 | 6,553,000 | 5,576,000 |
general and administrative | 18,467,000 | 16,386,000 | 16,121,000 | 13,531,000 | 12,898,000 | 9,069,000 | 10,942,000 | 11,694,000 | 11,408,000 | 10,755,000 | 10,351,000 | 10,786,000 | 12,081,000 | 10,514,000 | 8,042,000 | 8,585,000 | 7,549,000 | 6,939,000 | 5,749,000 | 4,164,000 |
total operating expenses | 39,717,000 | 38,479,000 | 36,743,000 | 34,491,000 | 35,132,000 | 30,666,000 | 33,253,000 | 33,963,000 | 33,747,000 | 33,185,000 | 33,598,000 | 37,289,000 | 33,200,000 | 29,290,000 | 25,502,000 | 25,452,000 | 22,534,000 | 22,319,000 | 18,380,000 | 15,934,000 |
income from operations | -18,463,000 | -5,594,000 | -9,192,000 | -10,624,000 | -14,975,000 | 2,986,000 | -4,248,000 | -8,527,000 | -10,734,000 | -137,000 | -6,420,000 | -9,127,000 | -12,162,000 | 84,000 | 1,360,000 | -891,000 | -2,357,000 | 1,317,000 | 2,897,000 | 3,811,000 |
yoy | 23.29% | -287.34% | 116.38% | 24.59% | 39.51% | -2279.56% | -33.83% | -6.57% | -11.74% | -263.10% | -572.06% | 924.35% | 415.99% | -93.62% | -53.05% | -123.38% | ||||
qoq | 230.05% | -39.14% | -13.48% | -29.06% | -601.51% | -170.29% | -50.18% | -20.56% | 7735.04% | -97.87% | -29.66% | -24.95% | -14578.57% | -93.82% | -252.64% | -62.20% | -278.97% | -54.54% | -23.98% | |
operating margin % | -41.83% | -9.00% | -17.58% | -23.30% | -36.12% | 5.20% | -8.25% | -18.29% | -23.93% | -0.24% | -13.38% | -18.37% | -32.79% | 0.17% | 3.36% | -2.22% | -6.72% | 3.39% | 8.43% | 12.53% |
other income: | ||||||||||||||||||||
interest expense | -262,000 | -299,750 | -494,000 | -414,000 | -291,000 | -173,500 | -119,000 | -134,000 | -441,000 | -394,000 | -595,000 | -409,000 | -673,000 | -687,000 | -649,000 | -647,000 | -590,000 | -492,000 | -441,000 | -433,000 |
interest income | 787,000 | -2,110,000 | 573,000 | 555,000 | 508,000 | 1,031,000 | 1,433,000 | 1,416,000 | 1,359,000 | 1,448,000 | 1,622,000 | 1,201,000 | 2,143,000 | 2,626,000 | 1,584,000 | 391,000 | 18,000 | 18,000 | 12,000 | 9,000 |
other income | 565,000 | 258,000 | 1,344,000 | 3,708,000 | 3,492,000 | 491,000 | 3,091,000 | 59,000 | 823,000 | 3,194,000 | 1,208,000 | 1,740,000 | 1,652,000 | -399,000 | -393,000 | -120,000 | ||||
total other income | 1,090,000 | 1,563,000 | 1,423,000 | 3,849,000 | 3,709,000 | 7,337,000 | 4,405,000 | 1,341,000 | 1,741,000 | 4,248,000 | 2,235,000 | 2,532,000 | 3,122,000 | 4,030,000 | 490,000 | -873,000 | -822,000 | -544,000 | ||
income before income taxes | -17,373,000 | -4,031,000 | -7,769,000 | -6,775,000 | -11,266,000 | 10,323,000 | 157,000 | -7,186,000 | -8,993,000 | 4,111,000 | -4,185,000 | -6,595,000 | -9,040,000 | 4,114,000 | 1,850,000 | -1,401,000 | -3,303,000 | 444,000 | 2,075,000 | 3,267,000 |
provision for income taxes | 1,493,000 | -1,192,000 | 136,000 | 680,000 | -784,000 | 3,248,000 | -1,392,000 | 2,271,000 | 396,000 | 224,000 | -699,000 | -1,145,000 | 1,609,000 | 655,000 | 597,000 | |||||
net income | -18,866,000 | -44,076,000 | -5,478,000 | -5,583,000 | -11,402,000 | 9,643,000 | 941,000 | -10,434,000 | -6,169,000 | 5,503,000 | -6,456,000 | -4,388,000 | -6,807,000 | 3,718,000 | 1,626,000 | -702,000 | -2,158,000 | -1,165,000 | 1,420,000 | 2,670,000 |
yoy | 65.46% | -557.08% | -682.15% | -46.49% | 84.83% | 75.23% | -114.58% | 137.78% | -9.37% | 48.01% | -497.05% | 525.07% | 215.43% | -419.14% | 14.51% | -126.29% | ||||
qoq | -57.20% | 704.60% | -1.88% | -51.03% | -218.24% | 924.76% | -109.02% | 69.14% | -212.10% | -185.24% | 47.13% | -35.54% | -283.08% | 128.66% | -331.62% | -67.47% | 85.24% | -182.04% | -46.82% | |
net income margin % | -42.75% | -70.93% | -10.48% | -12.24% | -27.50% | 16.78% | 1.83% | -22.38% | -13.75% | 9.45% | -13.45% | -8.83% | -18.35% | 7.69% | 4.02% | -1.75% | -6.15% | -3.00% | 4.13% | 8.78% |
net loss, basic and diluted | -18,866,000 | -5,583,000 | -11,402,000 | -10,434,000 | -6,169,000 | |||||||||||||||
net income per share | -0.15 | -0.045 | -0.04 | -0.04 | -0.09 | -0.03 | 0.01 | -0.08 | -0.05 | |||||||||||
weighted-average shares used for eps calculation | 128,704,934 | 127,745,939 | 127,547,859 | 126,934,294 | 128,339,481 | 130,611,330 | 131,003,744 | 131,440,486 | 130,920,971 | 135,283,044 | 136,173,278 | 135,918,707 | 135,489,194 | 134,510,831 | 134,711,701 | 134,403,059 | 133,902,523 | 76,741,858 | 108,322,433 | 31,878,762 |
comprehensive loss: | ||||||||||||||||||||
foreign currency translation adjustment, net of tax | 328 | 1,383 | 741 | 603 | -560 | -39 | 101 | 1,375 | -244 | 307 | 165 | -980 | -42 | -184 | -758 | -683 | 14 | 327 | 34 | 269 |
unrealized loss on marketable securities | -201 | -33 | -65 | -16 | -192 | |||||||||||||||
net comprehensive loss | -18,739 | -5,013 | -12,027 | -9,075 | -6,448 | -5,560 | -6,697 | |||||||||||||
benefit from income taxes | -836,750 | -2,291,000 | -2,824,000 | -2,207,000 | -2,233,000 | |||||||||||||||
net income, basic and diluted | -5,615,750 | -5,478,000 | -3,915,750 | 941,000 | ||||||||||||||||
comprehensive income: | ||||||||||||||||||||
unrealized gain on marketable securities | 38 | 118 | -47 | 195 | -35 | -3 | 15 | 152 | ||||||||||||
net comprehensive income | -5,414.75 | -4,619 | 9,557 | 1,237 | 5,807 | -6,276 | 3,551 | 868 | -1,385 | -2,144 | -838 | 1,454 | 2,939 | |||||||
less: net loss allocated to noncontrolling interests | -189,000 | 40,000 | 104,000 | 137,000 | ||||||||||||||||
net income attributable to common stockholders, basic and diluted | 5,503,000 | -6,456,000 | 3,529,000 | 1,666,000 | -598,000 | -2,021,000 | 346,000 | |||||||||||||
net income attributable to common stockholders per share, basic | 0.04 | -0.05 | 0.03 | 0.01 | -0.02 | |||||||||||||||
net income attributable to common stockholders per share, diluted | 0.04 | -0.05 | 0.03 | 0.01 | -0.02 | |||||||||||||||
net loss attributable to common stockholders, basic and diluted | -4,388,000 | -6,807,000 | ||||||||||||||||||
net loss attributable to common stockholders per share, basic and diluted | -0.03 | -0.05 | ||||||||||||||||||
other expense | 2,091,000 | -445,000 | -254,000 | -374,000 | ||||||||||||||||
less: net income allocated to participating securities | 1,191,000 | -1,074,000 | -2,670,000 | |||||||||||||||||
total other expense | -510,000 | -946,000 | ||||||||||||||||||
net income attributable to common stockholders per share diluted |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||
current assets: | ||||||||||||||||||||
cash and cash equivalents | 65,665,000 | 90,853,000 | 93,281,000 | 75,470,000 | 95,299,000 | 98,716,000 | 162,272,000 | 177,888,000 | 168,788,000 | 167,299,000 | 163,629,000 | 131,544,000 | 129,476,000 | 296,601,000 | 341,523,000 | 349,894,000 | 362,506,000 | 364,618,000 | 376,771,000 | 159,846,000 |
marketable securities | 196,560,000 | 170,676,000 | 168,453,000 | 186,552,000 | 170,314,000 | 179,145,000 | 115,505,000 | 99,323,000 | 101,298,000 | 95,111,000 | 124,392,000 | 167,294,000 | 169,519,000 | 44,548,000 | ||||||
trade accounts receivable | 51,903,000 | 62,509,000 | 56,632,000 | 56,232,000 | 55,029,000 | 60,588,000 | 52,634,000 | 44,643,000 | 50,306,000 | 55,928,000 | 55,402,000 | 49,624,000 | 43,100,000 | 48,864,000 | 39,636,000 | 36,811,000 | 30,406,000 | 29,760,000 | 29,450,000 | 24,029,000 |
inventories | 49,791,000 | 48,428,000 | 51,649,000 | 49,487,000 | 45,347,000 | 43,893,000 | 46,800,000 | 50,070,000 | 54,742,000 | 60,877,000 | 66,875,000 | 65,731,000 | 69,502,000 | 48,154,000 | 49,369,000 | 45,345,000 | 37,982,000 | 32,171,000 | 27,511,000 | 26,655,000 |
prepaid expenses and other current assets | 15,383,000 | 19,530,000 | 18,474,000 | 15,084,000 | 14,512,000 | 14,075,000 | 12,949,000 | 12,130,000 | 13,160,000 | 12,514,000 | 12,017,000 | 10,628,000 | 11,107,000 | 12,954,000 | 13,331,000 | 11,220,000 | 8,218,000 | 5,184,000 | 6,094,000 | 6,408,000 |
total current assets | 379,302,000 | 391,996,000 | 388,489,000 | 382,825,000 | 380,501,000 | 396,446,000 | 390,191,000 | 384,084,000 | 388,647,000 | 392,060,000 | 422,315,000 | 424,821,000 | 425,622,000 | 454,020,000 | 443,859,000 | 443,270,000 | 439,112,000 | 431,733,000 | 439,826,000 | 216,938,000 |
property and equipment | 20,469,000 | 18,009,000 | 18,046,000 | 18,352,000 | 17,834,000 | 17,962,000 | 18,508,000 | 18,114,000 | 18,247,000 | 18,405,000 | 17,415,000 | 15,588,000 | 15,549,000 | 13,682,000 | 7,844,000 | 7,340,000 | 6,504,000 | 5,851,000 | 4,982,000 | 3,895,000 |
operating lease right-of-use assets | 10,643,000 | 11,315,000 | 11,158,000 | 16,387,000 | 9,869,000 | 10,168,000 | 10,124,000 | 9,328,000 | 9,949,000 | 10,853,000 | 11,703,000 | 12,423,000 | 13,187,000 | 13,883,000 | 14,416,000 | 13,635,000 | 13,839,000 | |||
goodwill | 16,689,000 | 16,697,000 | 16,698,000 | 16,707,000 | 16,678,000 | 16,663,000 | 16,183,000 | 16,183,000 | 16,183,000 | 16,183,000 | 16,457,000 | 19,143,000 | 19,143,000 | 10,144,000 | 10,144,000 | 10,144,000 | 10,144,000 | 10,144,000 | 476,000 | 476,000 |
intangible assets | 15,704,000 | 16,821,000 | 17,676,000 | 18,601,000 | 19,431,000 | 20,128,000 | 20,492,000 | 21,420,000 | 22,252,000 | 23,084,000 | 24,292,000 | 23,683,000 | 24,664,000 | 4,331,000 | 4,485,000 | 3,859,000 | 4,328,000 | 4,739,000 | 361,000 | 333,000 |
other noncurrent assets | 6,306,000 | 6,704,000 | 4,459,000 | 4,683,000 | 4,574,000 | 4,759,000 | 4,950,000 | 4,920,000 | 4,081,000 | 3,385,000 | 3,168,000 | 3,009,000 | 3,006,000 | 2,957,000 | 4,559,000 | 2,880,000 | 1,264,000 | 1,665,000 | 1,297,000 | 1,259,000 |
total assets | 449,113,000 | 461,542,000 | 494,919,000 | 493,320,000 | 482,596,000 | 499,500,000 | 491,226,000 | 483,725,000 | 492,067,000 | 494,457,000 | 519,430,000 | 525,054,000 | 524,575,000 | 519,476,000 | 499,295,000 | 492,817,000 | 485,879,000 | 463,305,000 | 454,320,000 | 230,279,000 |
liabilities and stockholders’ equity | ||||||||||||||||||||
current liabilities: | ||||||||||||||||||||
trade accounts payable | 6,741,000 | 6,410,000 | 7,632,000 | 6,853,000 | 6,247,000 | 5,529,000 | 5,389,000 | 3,191,000 | 3,725,000 | 3,032,000 | 4,711,000 | 3,082,000 | 5,280,000 | 4,805,000 | 5,640,000 | 6,749,000 | 5,971,000 | 3,034,000 | 3,927,000 | 3,324,000 |
legal settlement liability, current | 2,208,000 | 2,495,000 | 2,177,000 | 1,968,000 | 1,705,000 | 1,705,000 | 2,496,000 | 2,503,000 | 2,550,000 | 2,561,000 | 2,600,000 | 1,918,000 | 1,906,000 | 2,163,000 | 2,175,000 | 2,139,000 | 1,554,000 | 1,463,000 | 7,405,000 | 7,229,000 |
accrued expenses | 19,781,000 | 23,417,000 | 20,233,000 | 21,604,000 | 19,197,000 | 21,443,000 | 20,733,000 | 15,489,000 | 18,054,000 | 20,035,000 | 20,514,000 | 19,591,000 | 20,366,000 | 21,126,000 | 16,637,000 | 17,841,000 | 14,640,000 | 15,251,000 | 10,753,000 | 11,593,000 |
other current liabilities | 22,173,000 | 16,978,000 | 16,426,000 | 14,717,000 | 12,836,000 | 13,494,000 | 8,814,000 | 7,228,000 | 8,228,000 | 7,903,000 | 7,821,000 | 8,388,000 | 10,861,000 | 7,960,000 | 4,949,000 | 5,630,000 | 8,386,000 | 6,352,000 | 2,044,000 | 1,351,000 |
deferred revenue, current | 30,032,000 | 28,504,000 | 28,739,000 | 28,128,000 | 27,706,000 | 25,492,000 | 25,365,000 | 23,968,000 | 23,009,000 | 22,695,000 | 23,047,000 | 20,612,000 | 18,104,000 | 12,986,000 | 12,093,000 | 9,991,000 | 12,252,000 | 7,081,000 | 5,885,000 | 4,668,000 |
total current liabilities | 80,935,000 | 77,804,000 | 75,207,000 | 73,270,000 | 67,691,000 | 67,663,000 | 62,797,000 | 52,379,000 | 55,566,000 | 56,226,000 | 58,693,000 | 53,591,000 | 56,517,000 | 49,040,000 | 41,494,000 | 42,350,000 | 42,803,000 | 33,181,000 | 30,014,000 | 28,165,000 |
legal settlement liability, noncurrent | 6,637,000 | 6,786,000 | 8,158,000 | 8,477,000 | 8,819,000 | 9,036,000 | 17,066,000 | 16,912,000 | 16,722,000 | 16,477,000 | 16,095,000 | 16,462,000 | 16,045,000 | 15,596,000 | 15,122,000 | 14,649,000 | 14,635,000 | 13,745,000 | 12,633,000 | 11,724,000 |
deferred revenue, noncurrent | 17,672,000 | 18,339,000 | 16,315,000 | 16,625,000 | 15,717,000 | 16,098,000 | 14,787,000 | 14,064,000 | 15,164,000 | 15,132,000 | 14,958,000 | 16,054,000 | 13,012,000 | 13,124,000 | 10,407,000 | 11,020,000 | 7,199,000 | 9,790,000 | 7,741,000 | 6,317,000 |
operating lease liability, noncurrent | 13,441,000 | 14,042,000 | 13,494,000 | 14,119,000 | 7,448,000 | 7,552,000 | 7,756,000 | 8,113,000 | 8,697,000 | 9,479,000 | 10,139,000 | 10,833,000 | 11,541,000 | 12,312,000 | 14,326,000 | 12,316,000 | ||||
long-term debt | 386,000 | |||||||||||||||||||
other noncurrent liabilities | 2,398,000 | 2,307,000 | 2,519,000 | 2,481,000 | 2,380,000 | 2,364,000 | 2,121,000 | 1,804,000 | 1,827,000 | 2,431,000 | 2,285,000 | 2,053,000 | 1,867,000 | 1,587,000 | 1,437,000 | 1,353,000 | 1,116,000 | 1,204,000 | 737,000 | 739,000 |
total liabilities | 121,469,000 | 119,803,000 | 116,348,000 | 115,763,000 | 102,973,000 | 103,763,000 | 105,763,000 | 94,602,000 | 99,453,000 | 101,393,000 | 103,906,000 | 100,875,000 | 101,115,000 | 93,930,000 | 82,786,000 | 81,688,000 | 78,437,000 | 57,920,000 | 51,125,000 | 46,945,000 |
commitments and contingencies | ||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||
common stock, 0.001 par value... | 129,000 | 129,000 | 128,000 | 127,000 | 128,000 | 129,000 | 130,000 | 132,000 | 131,000 | 131,000 | 136,000 | 136,000 | 136,000 | 135,000 | 135,000 | 135,000 | 134,000 | 126,000 | 125,000 | 24,000 |
additional paid-in capital | 445,750,000 | 441,107,000 | 435,284,000 | 429,652,000 | 426,705,000 | 430,791,000 | 430,072,000 | 434,967,000 | 429,384,000 | 423,386,000 | 451,648,000 | 454,027,000 | 447,748,000 | 442,887,000 | 437,401,000 | 432,889,000 | 427,818,000 | 423,625,000 | 420,600,000 | 7,975,000 |
accumulated deficit | -120,604,000 | -101,738,000 | -57,662,000 | -52,184,000 | -46,601,000 | -35,199,000 | -44,840,000 | -45,781,000 | -35,347,000 | -29,178,000 | -34,681,000 | -28,225,000 | -23,837,000 | -17,030,000 | -20,559,000 | -22,225,000 | -21,627,000 | -19,606,000 | -18,415,000 | -19,835,000 |
accumulated other comprehensive gain | 2,369,000 | 821,000 | -38,000 | -609,000 | 16,000 | 101,000 | ||||||||||||||
total stockholders’ equity | 327,644,000 | 341,739,000 | 378,571,000 | 377,557,000 | 379,623,000 | 395,737,000 | 385,463,000 | 389,123,000 | 392,614,000 | 393,064,000 | 415,524,000 | 424,179,000 | 423,460,000 | 425,546,000 | 416,509,000 | 411,129,000 | 407,442,000 | 405,385,000 | 403,195,000 | |
total liabilities and stockholders’ equity | 449,113,000 | 461,542,000 | 494,919,000 | 493,320,000 | 482,596,000 | 499,500,000 | 491,226,000 | 483,725,000 | 492,067,000 | 494,457,000 | 519,430,000 | 525,054,000 | 524,575,000 | |||||||
restricted cash | 29,000 | 31,000 | 30,000 | 353,000 | 331,000 | 2,918,000 | 2,899,000 | |||||||||||||
deferred income tax assets, noncurrent | 38,393,000 | 35,765,000 | 33,709,000 | 33,374,000 | 30,778,000 | 29,676,000 | 32,708,000 | 30,487,000 | 24,080,000 | 26,387,000 | 23,404,000 | 20,459,000 | 13,988,000 | 11,689,000 | 10,688,000 | 9,173,000 | 7,378,000 | 7,378,000 | ||
long term debt | 525,000 | 655,000 | 791,000 | 918,000 | 1,050,000 | 1,236,000 | 1,330,000 | 1,477,000 | 1,648,000 | 1,736,000 | 1,882,000 | 2,133,000 | 2,271,000 | |||||||
accumulated other comprehensive income | 2,241,000 | -697,000 | -530,000 | 228,000 | 911,000 | 897,000 | 570,000 | 536,000 | ||||||||||||
accumulated other comprehensive loss | -195,000 | -1,554,000 | -1,275,000 | -1,579,000 | -1,759,000 | -587,000 | ||||||||||||||
noncontrolling interest in consolidated subsidiary | 251,000 | 62,000 | 102,000 | 206,000 | 343,000 | 315,000 | 315,000 | |||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | ||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders’ equity | 519,476,000 | 499,295,000 | 492,817,000 | 485,879,000 | 463,305,000 | 454,320,000 | ||||||||||||||
redeemable convertible preferred stock, 0.001 par value... | 194,319,000 | |||||||||||||||||||
operating lease liability, non-current | 12,684,000 | |||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ deficit | ||||||||||||||||||||
stockholders’ deficit: | ||||||||||||||||||||
total stockholders’ deficit | -10,985,000 | |||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders’ deficit | 230,279,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||
net loss | -18,866,000 | -44,076,000 | -5,478,000 | -5,583,000 | -11,402,000 | 940,000 | -10,434,000 | -6,169,000 | -6,456,000 | -4,388,000 | -6,807,000 | ||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||
depreciation and amortization | 1,865,000 | 1,896,000 | 1,918,000 | 1,890,000 | 1,875,000 | 1,854,000 | 1,851,000 | 1,808,000 | 1,699,000 | 1,631,000 | 1,767,000 | 1,649,000 | 1,001,000 | 761,000 | 72,000 | 865,000 | 794,000 | 685,000 | 189,000 |
amortization of operating lease-right-of use assets | 948,000 | 1,147,000 | 1,142,000 | 1,098,000 | 1,009,000 | 672,000 | 761,000 | 794,000 | 792,000 | 796,000 | 800,000 | 1,103,000 | 699,000 | 689,000 | 676,000 | ||||
stock-based compensation | 4,861,000 | 5,527,000 | 5,638,000 | 6,790,000 | 6,630,000 | 7,003,000 | 7,053,000 | 7,152,000 | 5,640,000 | 5,669,000 | 5,758,000 | 5,922,000 | 4,699,000 | 4,465,000 | 4,359,000 | 3,934,000 | 3,837,000 | 3,008,000 | 2,455,000 |
loss on disposal of property and equipment | 55,000 | 60,000 | 102,000 | 152,000 | 101,000 | 3,000 | 0 | 5,000 | 47,000 | 0 | |||||||||
provision for credit losses | 459,000 | 311,000 | 50,000 | 121,000 | |||||||||||||||
provision for excess and obsolete inventory | 193,000 | 1,236,000 | 132,000 | 21,000 | 314,000 | 268,000 | 341,000 | 125,000 | 912,000 | 670,000 | 202,000 | 88,000 | 508,000 | 294,000 | 175,000 | 213,000 | 74,000 | 155,000 | 70,000 |
deferred income taxes | -183,000 | 38,576,000 | -2,627,000 | -2,056,000 | -336,000 | ||||||||||||||
gain on investments, accretion, and amortization | -1,255,000 | -1,212,000 | -1,580,000 | -1,246,000 | -1,183,000 | -1,202,000 | -1,396,000 | -1,561,000 | -2,124,000 | -1,580,000 | |||||||||
interest expenses for accretion of the legal settlement liabilities | -47,000 | -761,000 | 141,000 | 144,000 | 148,000 | -7,704,000 | 65,000 | 146,000 | 301,000 | 266,000 | 480,000 | 287,000 | 544,000 | 567,000 | 564,000 | 549,000 | 498,000 | 475,000 | 439,000 |
other non-cash expense | 236,000 | ||||||||||||||||||
change in operating assets and liabilities: | |||||||||||||||||||
trade accounts receivable | 9,645,000 | -6,146,000 | -587,000 | 652,000 | 6,449,000 | -9,329,000 | -6,252,000 | 5,918,000 | 4,235,000 | 263,000 | -6,850,000 | -6,800,000 | 6,055,000 | -7,964,000 | -3,816,000 | -6,926,000 | -1,038,000 | -720,000 | -5,593,000 |
inventories | -1,627,000 | 2,051,000 | -2,222,000 | -3,570,000 | -1,503,000 | 2,000,000 | 3,556,000 | 4,426,000 | 4,773,000 | 6,333,000 | -1,888,000 | 3,029,000 | -3,188,000 | 1,884,000 | -5,182,000 | -8,434,000 | -5,921,000 | -2,230,000 | -964,000 |
prepaid expenses and other assets | 3,853,000 | -3,353,000 | 1,114,000 | -270,000 | -149,000 | -742,000 | -2,610,000 | 3,468,000 | -2,925,000 | -7,179,000 | 833,000 | -3,033,000 | -136,000 | -4,327,000 | -6,371,000 | -4,313,000 | -4,351,000 | -1,250,000 | -2,445,000 |
trade accounts payable | 390,000 | -1,309,000 | 588,000 | 759,000 | 410,000 | 258,000 | 2,228,000 | -519,000 | 615,000 | -1,794,000 | 1,709,000 | -2,004,000 | 305,000 | -908,000 | -907,000 | 895,000 | 2,782,000 | -742,000 | 635,000 |
accrued expenses and other liabilities | -3,890,000 | 4,709,000 | -1,409,000 | 2,791,000 | -2,121,000 | 2,938,000 | 5,634,000 | -4,790,000 | -4,599,000 | 119,000 | 335,000 | -1,488,000 | 1,763,000 | 4,642,000 | 44,000 | 2,229,000 | 555,000 | 8,879,000 | 1,594,000 |
legal settlement liabilities | -389,000 | -293,000 | -252,000 | -223,000 | -365,000 | -1,116,000 | 81,000 | -3,000 | -67,000 | 76,000 | -164,000 | 141,000 | -351,000 | -105,000 | -55,000 | 51,000 | 482,000 | -5,305,000 | 647,000 |
operating lease liabilities | -159,000 | -1,079,000 | -1,162,000 | -1,035,000 | -1,140,000 | -433,000 | -727,000 | ||||||||||||
deferred revenue | 1,175,000 | 1,736,000 | 284,000 | 238,000 | 1,343,000 | 1,393,000 | 1,762,000 | 40,000 | 542,000 | -696,000 | 1,495,000 | 5,770,000 | -49,000 | 2,915,000 | 1,898,000 | 2,017,000 | 2,581,000 | 3,375,000 | 2,714,000 |
net cash from operating activities | -2,736,000 | -771,000 | -3,898,000 | 108,000 | -125,000 | 1,997,000 | 13,221,000 | 6,204,000 | 3,957,000 | 9,512,000 | -4,239,000 | -2,850,000 | 2,858,000 | 6,193,000 | -7,504,000 | -9,440,000 | -1,480,000 | 5,448,000 | 1,161,000 |
capital expenditures | -2,168,000 | -1,001,000 | -657,000 | -1,577,000 | -849,000 | -894,000 | -1,011,000 | -1,053,000 | -567,000 | -1,500,000 | -1,330,000 | -1,313,000 | -505,000 | -6,530,000 | -1,110,000 | -1,328,000 | -780,000 | -1,296,000 | -1,308,000 |
free cash flows | -4,904,000 | -1,772,000 | -4,555,000 | -1,469,000 | -974,000 | 1,103,000 | 12,210,000 | 5,151,000 | 3,390,000 | 8,012,000 | -5,569,000 | -4,163,000 | 2,353,000 | -337,000 | -8,614,000 | -10,768,000 | -2,260,000 | 4,152,000 | -147,000 |
cash flows from investing activities: | |||||||||||||||||||
purchases of marketable securities | -95,598,000 | -77,108,000 | -59,624,000 | -81,262,000 | -60,161,000 | -107,250,000 | -52,827,000 | -36,853,000 | -77,132,000 | -23,372,000 | -23,482,000 | -5,842,000 | -123,239,000 | ||||||
proceeds from maturities of marketable securities | 70,714,000 | 79,200,000 | 66,475,000 | 70,431,000 | 38,000,000 | 40,000,000 | 72,000,000 | 68,000,000 | |||||||||||
proceeds from sale of property and equipment | 6,000 | 1,000 | 23,000 | 33,000 | 21,000 | ||||||||||||||
purchase of property and equipment | -2,168,000 | -1,001,000 | -657,000 | -1,577,000 | -849,000 | -894,000 | -1,011,000 | -1,053,000 | -567,000 | -1,500,000 | -1,330,000 | -1,313,000 | -505,000 | -6,530,000 | -1,110,000 | -1,328,000 | -780,000 | -1,296,000 | -1,308,000 |
purchase of intangible assets | -33,000 | -32,000 | 2,000 | -74,000 | -2,000 | -9,000 | 8,000 | -148,000 | -55,000 | -61,000 | -63,000 | -80,000 | |||||||
net cash from investing activities | -27,079,000 | -1,842,000 | 18,920,000 | -16,413,000 | 9,452,000 | -63,433,000 | -15,809,000 | 2,022,000 | -5,754,000 | 29,066,000 | 43,124,000 | 2,790,000 | -168,874,000 | -51,064,000 | -1,150,000 | -2,915,000 | -780,000 | -18,296,000 | -1,308,000 |
cash flows from financing activities: | |||||||||||||||||||
repayment of loan | -869,000 | -2,940,000 | -145,000 | -142,000 | -1,518,000 | -139,000 | -140,000 | -139,000 | -139,000 | -140,000 | -138,000 | -141,000 | -146,000 | ||||||
payments for taxes related to net share settlement of equity awards | -239,000 | -268,000 | -171,000 | -102,000 | -129,000 | -130,000 | -146,000 | -130,000 | -148,000 | -102,000 | -149,000 | -111,000 | -57,000 | -71,000 | -71,000 | ||||
proceeds from issuance of common stock under employee stock plans | 21,000 | 85,000 | 137,000 | 64,000 | 39,000 | 138,000 | 147,000 | 224,000 | 506,000 | 341,000 | 441,000 | 483,000 | 203,000 | 168,000 | 226,000 | ||||
proceeds from line of credit | 5,068,000 | 1,416,000 | 2,091,000 | 1,385,000 | 690,000 | 2,785,000 | 5,000 | -3,000 | 1,394,000 | ||||||||||
payments for repurchase of shares | 29,000 | -4,510,000 | -10,627,000 | -11,950,000 | -8,428,000 | ||||||||||||||
net cash from financing activities | 3,981,000 | -1,226,000 | 1,941,000 | -2,602,000 | -11,545,000 | -3,640,000 | -12,084,000 | -1,711,000 | 1,613,000 | -33,754,000 | -8,274,000 | 3,850,000 | 155,000 | 1,144,000 | 364,000 | 17,000 | 217,078,000 | ||
effect of exchange rate changes on cash and cash equivalents | 646,000 | 128,000 | -1,401,000 | -216,000 | |||||||||||||||
cash and cash equivalents: | |||||||||||||||||||
net (decrease) in cash and cash equivalents | -25,188,000 | ||||||||||||||||||
cash and cash equivalents at beginning of period | 90,853,000 | 0 | 0 | 364,618,000 | |||||||||||||||
cash and cash equivalents at end of period | 65,665,000 | -8,371,000 | -12,612,000 | 362,506,000 | |||||||||||||||
supplemental disclosure of cash flow information: | |||||||||||||||||||
cash paid for taxes, net of refunds | -3,748,000 | ||||||||||||||||||
interest received on tax refunds | -180,000 | ||||||||||||||||||
non-cash investing and financing activities: | |||||||||||||||||||
fixed asset purchases in accounts payable or accrued purchase at period end | 1,308,000 | 45,000 | -194,000 | 234,000 | -24,000 | -165,000 | 288,000 | ||||||||||||
intangible asset in accounts payable or accrued expenses at period end | 3,000 | -5,000 | -31,000 | 47,000 | 46,000 | ||||||||||||||
operating lease right-of-use assets obtained in exchange for operating lease liabilities | 7,434,000 | 599,000 | |||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||
lease liabilities | -709,000 | -706,000 | -877,000 | -610,000 | -507,000 | -291,000 | |||||||||||||
maturities of marketable securities | |||||||||||||||||||
proceeds from sales of property and equipment | |||||||||||||||||||
acquisition of business | 0 | -1,000 | 0 | -44,895,000 | |||||||||||||||
payment for additional investment in cytek japan, net of cash acquired | 0 | 0 | |||||||||||||||||
payment for repurchase of shares | |||||||||||||||||||
proceeds from employee stock purchase plan | 446,000 | 0 | 697,000 | 0 | 889,000 | 0 | 820,000 | 0 | |||||||||||
effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,412,000 | 846,000 | -921,000 | -1,228,000 | 1,518,000 | -943,000 | 2,262,000 | 1,695,000 | -823,000 | 1,474,000 | -1,006,000 | -1,090,000 | 678,000 | -6,000 | |||||
cash, cash equivalents and restricted cash: | |||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -63,558,000 | 32,085,000 | -850,000 | -167,106,000 | |||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 0 | 0 | 0 | 98,745,000 | 0 | 0 | 0 | 167,630,000 | 0 | 0 | 0 | 299,500,000 | 0 | 0 | |||||
cash, cash equivalents and restricted cash at end of period | -2,428,000 | 17,811,000 | -19,829,000 | 95,299,000 | -63,558,000 | -15,615,000 | 8,777,000 | 169,141,000 | 4,001,000 | 32,085,000 | -850,000 | 132,394,000 | -12,153,000 | 216,925,000 | |||||
fixed asset purchases in accounts payable at period end | 66,000 | -109,000 | 139,000 | -168,000 | -16,000 | 23,000 | 228,000 | -175,000 | -29,000 | ||||||||||
intangible asset in accrued expenses at period end | 1,000 | 4,000 | 4,000 | -39,000 | 29,000 | 0 | 40,000 | 3,000 | |||||||||||
accrued excise taxes for share repurchase | |||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 17,810,000 | -19,829,000 | -3,446,000 | 8,777,000 | 1,511,000 | -12,153,000 | 216,925,000 | ||||||||||||
cash paid for taxes | 0 | 1,906,000 | 864,000 | 4,495,000 | 127,000 | 590,000 | 93,000 | 460,000 | 2,273,000 | 7,582,000 | 75,000 | 625,000 | 231,000 | ||||||
transfer of inventory to property and equipment | 31,000 | ||||||||||||||||||
derecognition of right-of-use assets | |||||||||||||||||||
operating lease right-of-use assets obtained in exchange for operating lease liabilities, net of tenant improvement receivable | |||||||||||||||||||
loss on investments, accretion, and amortization | -1,615,000 | -1,493,000 | |||||||||||||||||
net income | 3,718,000 | 1,626,000 | -702,000 | -2,158,000 | -1,165,000 | 1,420,000 | |||||||||||||
allowance for credit losses | |||||||||||||||||||
payment for investment | 0 | ||||||||||||||||||
proceeds from loan | |||||||||||||||||||
amortization of operating lease right-of-use assets | |||||||||||||||||||
(benefits from) provision for credit losses | 0 | ||||||||||||||||||
payment for additional investment in cytek japan | 0 | 0 | -235,000 | ||||||||||||||||
gain on equity method investment | 0 | 0 | |||||||||||||||||
loss on lease exit cost | |||||||||||||||||||
repayment of paycheck protection program loan | 0 | 0 | |||||||||||||||||
proceeds from initial public offering, net of underwriting discounts and commissions and other offering costs | 0 | ||||||||||||||||||
increase in accounts receivable allowance for credit losses | 41,000 | ||||||||||||||||||
payment of investment | |||||||||||||||||||
allowance for doubtful accounts | |||||||||||||||||||
proceeds from paycheck protection program loan | |||||||||||||||||||
net proceeds from issuance of series d redeemable convertible preferred stock | |||||||||||||||||||
stock option exercise in other receivables at period end | |||||||||||||||||||
common stock issuance for legal settlement | |||||||||||||||||||
net increase in cash and cash equivalents | -8,371,000 | -12,612,000 | -2,112,000 | ||||||||||||||||
payment of deferred offering cost | |||||||||||||||||||
stock option exercise in accounts receivable at period end | |||||||||||||||||||
deferred financing costs in accounts payable at period end | |||||||||||||||||||
proceeds from issuance of common stock upon exercise of stock options | 364,000 | 17,000 | 308,000 | ||||||||||||||||
payment of deferred offering costs | |||||||||||||||||||
deferred offering costs in accrued expenses at period end |